Actos is a drug used to treat Type 2 Diabetes developed by Takeda Pharmaceuticals and approved by the FDA in July of 1999.  Studies published this past summer showed patients using Actos have a 40% increase in the risk of developing bladder cancer.  Heart attacks and other health problems have also been associated with Actos.  In light of these studies France and Germany banned the drug.  The FDA has approved new labeling for the drug, requiring it to state that if a patient uses Actos for more than one year, it may cause bladder cancer.

             For some this may be too little too late.  Bloomberg News is reporting that thousands of Actos patients have contacted plaintiff lawyers because they have developed bladder cancer after taking Actos for Type 2 Diabetes.  This number will probably reach into the tens of thousands.  These lawsuits claim that patients have an increased risk of bladder cancer AND Takeda knew about the risks and withheld information about these risks along with failing to provide adequate warnings.

             The many lawsuits have been consolidated into U.S. District Court, Western District of Louisiana, Lafayette.  The Honorable Judge Rebecca Doherty will be presiding.  The choice to consolidate the lawsuits saves time and money and reduces any duplicating lawsuits. The official name of the consolidated lawsuits is In Re: Actos Products Liability Litigation, MD 2299, U.S. District Court, Western District of Louisiana (Lafayette).

 If you or a loved one has been diagnosed with bladder cancer or any other side effects after taking the Type 2 Diabetes Drug, Actos, please contact The Kerr Law Firm at 1-800-350-2990 or locally at 1-843-785-3330.  You may also email us at info@kerrlf.com.  We will help you get the compensation you deserve.